2019 Documentation HIV Treatment and Prevention Agents 
ISPE
JULY 6, 2023
1 , 4 A Retrospective Journey In 2015, Vertex’s Orkambi was the first approved drug produced under a CM process for the treatment of cystic fibrosis. Vertex continued to invest in CM with two additional approved drugs—Symdeco/Symkevi in 2018 and Trikafta in 2019—with the same indication. 8 (November/December 2019):26–29.
The Thyroid Pharmacist
JANUARY 20, 2023
Nikolai Lazarev defined adaptogens as “an agent that raises the body’s ability to resist stress by countering undesired stressors, whether physical, chemical, emotional, or biological.” The first case is outlined in a 2019 report by Roberto Vita and his research team, and published in Revista da Associação Médica Brasileira.
Expert insights. Personalized for you.
52 
Let's personalize your content